CAR-T therapy helps stiff person syndrome patients walk and work again
Patients with stiff person syndrome have shown significant improvement after receiving CAR-T cell therapy, regaining mobility and independence. Those who received the therapy were able to return to work and resume daily activities. The treatment appears to target the underlying cause of the disease.
Why it's good news: It offers a potential solution to a debilitating condition that affects people's quality of life.
The health section covers stories about medical progress, recovery, and wellbeing. We look for genuine advances: new therapies clearing regulatory hurdles, diseases being eradicated in specific regions, communities improving public health outcomes through evidence-based programs. Celebrity wellness trends and supplement marketing do not make the cut.
The morning letter delivers the day's best positive headlines before the rest of the internet gets loud. Free, no tracking, one click to leave.
Get the morning letter →More Health stories
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →